8,000 Shares in Medtronic PLC (NYSE:MDT) Purchased by National Mutual Insurance Federation of Agricultural Cooperatives

National Mutual Insurance Federation of Agricultural Cooperatives acquired a new position in Medtronic PLC (NYSE:MDT) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 8,000 shares of the medical technology company’s stock, valued at approximately $779,000.

A number of other large investors have also added to or reduced their stakes in MDT. Cornerstone Advisors Inc. lifted its position in shares of Medtronic by 8.1% during the second quarter. Cornerstone Advisors Inc. now owns 1,621 shares of the medical technology company’s stock valued at $158,000 after buying an additional 122 shares during the last quarter. Patriot Financial Group Insurance Agency LLC raised its position in shares of Medtronic by 3.1% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 4,129 shares of the medical technology company’s stock valued at $376,000 after purchasing an additional 126 shares during the last quarter. Hanson & Doremus Investment Management raised its position in shares of Medtronic by 0.9% in the 1st quarter. Hanson & Doremus Investment Management now owns 14,416 shares of the medical technology company’s stock valued at $1,313,000 after purchasing an additional 128 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Medtronic by 9.8% in the 1st quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the medical technology company’s stock valued at $131,000 after purchasing an additional 128 shares during the last quarter. Finally, Merit Financial Group LLC raised its position in shares of Medtronic by 3.4% in the 1st quarter. Merit Financial Group LLC now owns 4,182 shares of the medical technology company’s stock valued at $380,000 after purchasing an additional 136 shares during the last quarter. 80.65% of the stock is owned by institutional investors.

Several equities analysts recently commented on MDT shares. Northland Securities reaffirmed a “hold” rating and issued a $100.00 price objective on shares of Medtronic in a research report on Thursday, June 20th. Cowen reaffirmed an “outperform” rating and issued a $111.00 price objective (up from $99.00) on shares of Medtronic in a research report on Wednesday. Oppenheimer set a $110.00 price objective on shares of Medtronic and gave the company a “buy” rating in a research report on Monday, July 15th. Morgan Stanley increased their price objective on shares of Medtronic from $100.00 to $105.00 and gave the company an “equal weight” rating in a research report on Wednesday. Finally, UBS Group increased their price objective on shares of Medtronic to $112.00 and gave the company a “buy” rating in a research report on Friday, June 14th. Seven research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $106.86.



In other news, SVP Bradley E. Lerman sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $100.31, for a total transaction of $401,240.00. Following the sale, the senior vice president now owns 52,906 shares of the company’s stock, valued at approximately $5,307,000.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Richard Kuntz sold 3,438 shares of the firm’s stock in a transaction that occurred on Monday, July 22nd. The stock was sold at an average price of $101.12, for a total transaction of $347,650.56. The disclosure for this sale can be found here. Insiders have sold a total of 95,701 shares of company stock worth $9,318,744 in the last ninety days. Corporate insiders own 0.28% of the company’s stock.

NYSE:MDT traded up $1.17 during midday trading on Friday, hitting $102.92. The company’s stock had a trading volume of 151,522 shares, compared to its average volume of 4,209,665. Medtronic PLC has a fifty-two week low of $81.66 and a fifty-two week high of $103.95. The firm’s 50 day moving average is $100.44 and its 200-day moving average is $93.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.59 and a quick ratio of 2.15. The firm has a market cap of $137.33 billion, a P/E ratio of 19.72, a P/E/G ratio of 2.62 and a beta of 0.67.

Medtronic (NYSE:MDT) last issued its quarterly earnings results on Thursday, May 23rd. The medical technology company reported $1.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.47 by $0.07. The company had revenue of $8.15 billion for the quarter, compared to the consensus estimate of $8.12 billion. Medtronic had a net margin of 15.15% and a return on equity of 14.16%. Medtronic’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.42 EPS. As a group, analysts forecast that Medtronic PLC will post 5.48 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 25th. Stockholders of record on Monday, July 8th were paid a dividend of $0.54 per share. This is a boost from Medtronic’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Friday, July 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.10%. Medtronic’s dividend payout ratio (DPR) is presently 41.38%.

Medtronic Company Profile

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

Featured Article: What is a Buy-Side Analyst?

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.